↓ Skip to main content

Dose reduction of the new generation biologics (IL-17 and IL-23 inhibitors) in psoriasis: study protocol for an international, pragmatic, multicenter, randomized, controlled, non-inferiority study—the…

Overview of attention for article published in Trials, October 2021
Altmetric Badge

Citations

dimensions_citation
9 Dimensions

Readers on

mendeley
32 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Dose reduction of the new generation biologics (IL-17 and IL-23 inhibitors) in psoriasis: study protocol for an international, pragmatic, multicenter, randomized, controlled, non-inferiority study—the BeNeBio study
Published in
Trials, October 2021
DOI 10.1186/s13063-021-05681-z
Pubmed ID
Authors

Lara S. van der Schoot, Juul M. P. A. van den Reek, Lynda Grine, Lisa Schots, Wietske Kievit, Jo L. W. Lambert, Elke M. G. J. de Jong

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 32 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 32 100%

Demographic breakdown

Readers by professional status Count As %
Other 4 13%
Researcher 4 13%
Student > Bachelor 3 9%
Student > Ph. D. Student 2 6%
Student > Master 2 6%
Other 3 9%
Unknown 14 44%
Readers by discipline Count As %
Medicine and Dentistry 8 25%
Pharmacology, Toxicology and Pharmaceutical Science 2 6%
Biochemistry, Genetics and Molecular Biology 1 3%
Agricultural and Biological Sciences 1 3%
Arts and Humanities 1 3%
Other 4 13%
Unknown 15 47%